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DrCarlos Timaran (Dallas, Tex). Dr Lin and colleagues have
presented an important study about a problem that is being seen
more frequently by vascular surgeons as we embrace carotid angio-
plasty and stenting (CAS). As shown in this study, CASmay induce
bradycardia and hypotension that may be associated with adverse
outcomes if not resolved expeditiously. CAS-induced bradycardia
is typically short lived, whereas hypotension is more persistent.
Because CAS is currently reserved primarily for high-risk patients,
hemodynamic changes could potentially result in significant mor-
bidity and mortality, particularly in patients with severe cardiovas-
cular disease. Moreover, this study has revealed that elderly pa-
tients and those with severely depressed cardiac function are at
higher risk of developing CAS-induced hemodynamic depression.
Based on the results of the current study, I have the following
comments and questions:
First, in the multivariate logistic regression models included in
your paper, age groups were analyzed rather than age as a contin-
uous variable. This is a rather unfortunate, as most statisticians
would agree that continuous variables should be maintained con-
tinuous. Did you analyze age as a continuous variable in separate
models? If you did, what is the age cutoff value above which the
risk of hemodynamic changes is more significant? It appears that
octogenarians have the highest risk in this series. Do you believe
that because of this additional risk factor, CAS should definitely be
avoided in octogenarians?
Second, in this series, CAS-induced bradycardia was treated
with atropine and hypotension with dopamine. The use of atropine
during CAS is controversial as it has significant side effects, partic-
ularly in elderly and high-risk patients, including mental status
changes and persistent tachycardia that may lead to myocardial
ischemia. Dopamine, on the other hand, can also induce tachycar-
dia and arrhythmias and its mechanism of action does not treat the
physiologic changes induced by stretching the carotid sinus.More-
over, because atropine and dopamine produce tachycardia through
different mechanisms, their actions could be additive even syner-
gistic. What was the incidence of persistent hypertension or tachy-
cardia related to the use of atropine and dopamine? What was the
incidence of treatment-induced arrhythmias, angina and myocar-
dial infections?
Third, atropine is rarely used these days as an adjunct to
general anesthesia because of its serious adverse effects. Glycopyr-of its limited half-life. Why haven’t the authors used it instead of
atropine? What do the authors think about using vasopressors with
mechanisms of action that have more physiologic basis for the
treatment of CAS-induced hypotension, such as ephedrine and
norepinephrine.
Finally, I would like your input regarding a patient I had to
treat several weeks ago. This was an 81-year-old patient with
symptomatic carotid stenosis, unstable angina, 80% stenosis of the
left main, and 99% stenosis of the right coronary arteries. His
ejection fraction was 25%. According to your data, this patient has
a high risk of adverse outcome. How would you treat this patient
considering that his coronary artery disease was deemed nonrecon-
structable? I may consider transferring patients like this to Hous-
ton if you have the right answer.
I want to thank the authors for sending me their manuscript in
advance and the association for the honor of discussing this impor-
tant study and the privilege of the floor.
Dr Peter H. Lin: Regarding your first question, which deals
with the statistical analyses of the age factor as a continuous
variable as well as the categorical variable, we did perform analysis
using age as a continuous variable and similarly discovered that
increased age was associated with an increased risk of hemody-
namic depression.
With that said, I think it is premature to draw a conclusion
based on this study to say that carotid stenting is indeed contrain-
dicated or avoided in elderly patients. There are many factors that
can lead to the development of bradycardia or hypotension in
elderly patients. One potential issue that comes to my mind is that
many of these octogenarian patients are perhaps hypovolemic;
particularly, many of these patients may have underlying left ven-
tricular dysfunction, whichmay lower the threshold of sympathetic
activation. As such, elderly patients who are dehydrated with
suppressed cardiac function are more likely to develop hemody-
namic depression following baroreceptor stimulation. One learn-
ing point that we can draw from our experience is that interven-
tionalists should have a higher level of awareness when performing
carotid stenting in elderly patients who might have compromised
cardiac function. These patients should be appropriately hydrated
during this procedure to reduce the likelihood of postprocedural
hypotension or carotid sinus activation.
Your second question relates to the use of atropine and
dopamine. In our practice, we only administer intravenous atro-
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selective atropine administration is very effective in reversing
carotid-stenting-induced bradycardia. I do want to point out a
technical step in our practice with regards to atropine administra-
tion. Whenever we are about to perform balloon dilation of the
carotid artery or deploy a carotid stent, we have an OR nurse or
nurse anesthetist read the heart rate loudly in the operating room
so that everyone in the operating room can receive an audible
readout of the heart rate. The decision of atropine administration is
clearly communicated with everyone participating in the stenting
procedures, including the surgeons, anesthesiologists, nurses, res-
idents, and even medical students. In no instance do we have to
administer additional atropine once patients leave the operating
room. I do have to emphasize that we have the advantage because
all carotid stenting procedures were done in the operating room
with staff anesthesiology monitoring, and we have been very
satisfied with added staff support in the way these patients are
monitored.
With regards to your third question, we do not have experi-
ence with glycopyrrolate to treat patients with bradycardia. Addi-
tionally, we have not experience any side effects of atropine,
although we fully recognize that this drug can cause hypotension,
particularly in patients who are hypovolemic. With that said, our
treatment approach in patients who developed post-stenting hy-potension is to provide fluid resuscitation first. After a liter or so of
fluid, which obviously depends on the patient’s cardiac function,
we will put a central line in to monitor their intravenous pressure
and follow-up by appropriate vasopressor agent administration.
With regard to your last question of an 80-year old gentleman
with increased cardiac morbidities, clearly it is difficult to answer
that question based on brief history. However, I do think that
carotid endarterectomy under local anesthesia remains an excellent
treatment option even in high-risk patients with carotid artery
stenosis. I was fortunate to receive my vascular surgery fellowship
training at Emory University School of Medicine where I learned
the art of carotid endarterectomy under local anesthesia from
surgeons such as Drs Bob Smith, Atef Salamn, Tom Dodson, and
Eliot Chaikof. To this date, I continue to perform carotid endar-
terectomy under local anesthesia in my practice. In patients who
have anatomical concern to undergo carotid stenting, we have
shown in our experience that carotid endarterectomy under local
anesthesia is clearly an excellent treatment option even in elderly
patients. Therefore based on the scenario you provided, I would
consider both options in the overall treatment strategy. The car-
diac comorbidities that you had mentioned would not preclude
this patient from undergoing carotid endarterectomy under local
anesthesia.
